Origami Therapeutics

Origami is discovering oral drugs to halt neurodegeneration. Their approach involves eliminating the toxic proteins that are the underlying cause of neurodegeneration using protein degraders to restore normal function. Origami’s discovery platform leverages our proprietary human disease models to select the drugs with the best chance of clinical success.